TickerFacts.

A business in context

RNAC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001453687-26-000101

  2. 8-K · Current report

    Report date 2026-08-06 · 0001453687-26-000100 · Items 2.02,9.01

  3. 8-K · Current report

    Report date 2026-06-12 · 0001453687-26-000090 · Items 5.07

  4. 8-K · Current report

    Report date 2026-06-09 · 0001140361-26-024556 · Items 7.01,9.01

  5. 8-K · Current report

    Report date 2026-05-22 · 0001453687-26-000087 · Items 1.01,2.03,3.02,5.02,7.01,9.01

  6. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001453687-26-000082

  7. 8-K · Current report

    Report date 2026-04-30 · 0001453687-26-000081 · Items 2.02,9.01

  8. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001453687-26-000072

  9. 4 · Ownership change

    Report date 2026-04-02 · 0002064832-26-000149

  10. 4 · Ownership change

    Report date 2026-04-02 · 0002064832-26-000148

  11. 8-K · Current report

    Report date 2026-03-26 · 0001453687-26-000068 · Items 5.02

  12. 4 · Ownership change

    Report date 2026-03-13 · 0001453687-26-000066

  13. 10-K · Annual report

    Report date 2025-12-31 · 0001453687-26-000064

  14. 8-K · Current report

    Report date 2026-03-09 · 0001453687-26-000063 · Items 2.02,9.01

  15. 8-K · Current report

    Report date 2026-01-09 · 0001453687-26-000051 · Items 7.01,9.01

  16. 4 · Ownership change

    Report date 2026-01-06 · 0001453687-26-000047

  17. 4 · Ownership change

    Report date 2026-01-06 · 0001453687-26-000046

  18. 4 · Ownership change

    Report date 2026-01-06 · 0001453687-26-000045

  19. 4 · Ownership change

    Report date 2026-01-02 · 0001453687-26-000039

  20. 4 · Ownership change

    Report date 2026-01-02 · 0001453687-26-000038

  21. 8-K · Current report

    Report date 2025-12-16 · 0001453687-25-000140 · Items 5.02,5.05,7.01,9.01

  22. 8-K · Current report

    Report date 2025-11-13 · 0001453687-25-000123 · Items 7.01,8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001453687-25-000120

  24. 8-K · Current report

    Report date 2025-11-06 · 0001453687-25-000119 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-10-29 · 0001140361-25-039793 · Items 5.02,5.03,7.01,9.01

  26. 8-K · Current report

    Report date 2025-10-15 · 0001453687-25-000106 · Items 5.02

  27. 8-K · Current report

    Report date 2025-10-02 · 0001453687-25-000104 · Items 5.02

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001453687-25-000099

  29. 8-K · Current report

    Report date 2025-08-07 · 0001453687-25-000098 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-06-13 · 0001453687-25-000093 · Items 5.07

  31. 8-K · Current report

    Report date 2025-05-30 · 0001453687-25-000091 · Items 8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001453687-25-000085

  33. 8-K · Current report

    Report date 2025-05-08 · 0001453687-25-000084 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-04-29 · 0001453687-25-000077 · Items 5.02

  35. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001453687-25-000075

  36. 8-K · Current report

    Report date 2025-04-08 · 0001453687-25-000064 · Items 7.01,8.01,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001453687-25-000060

  38. 8-K · Current report

    Report date 2025-03-13 · 0001453687-25-000059 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-03-03 · 0001453687-25-000054 · Items 7.01,9.01

  40. 8-K · Current report

    Report date 2025-01-27 · 0001453687-25-000050 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 4 transaction rows4MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

4 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-04-02
2026-04-06
Hoge Elizabeth; Seven One Eight Three Four Irrevocable TrustM · Exercise / conversion
Acquired
Common Stock758001.0—
2026-04-02
2026-04-06
Hoge Elizabeth; Seven One Eight Three Four Irrevocable TrustM · Exercise / conversion
Disposed
Series A Non-Voting Convertible Preferred Stock
Derivative security
22740.03—
2026-04-02
2026-04-06
Kalayoglu MuratM · Exercise / conversion
Acquired
Common Stock758001.0—
2026-04-02
2026-04-06
Kalayoglu MuratM · Exercise / conversion
Disposed
Series A Non-Voting Convertible Preferred Stock
Derivative security
22740.03—

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001453687Cartesian Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
529900NMN0LACZOL7C43
GLEIF legal name
CARTESIAN THERAPEUTICS, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-07-28T07:39:42Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Selecta Biosciences (United States) · alias · wikidata
  • SELECTA BIOSCIENCES INC · former SEC name · 2009-01-05 to 2023-11-13
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$38.27M$40.74M
2023-12-31$26.00M$28.50M
2022-12-31$110.78M$126.38M
2021-12-31$85.08M$104.82M
2020-12-31$16.60M$21.41M
2019-12-31$6.68M$8.72M
2018-12-31$903.0K$1.20M
2017-12-31$207.0K$282.0K

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗